A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the same population. Estimated increases in intervention exposure do not fully explain the decrease in risk. We investigate whether the underlying contact network structure and differences in the structure of the RDS trees could have contributed to the apparent change in incidence. Method We analyse the samples for evidence that individuals recruit participants who are like themselves (assortative recruiting). Using an assortativity measure, we develop a Monte Carlo approach to determine whether the RDS data exhibi...
Abstract: Several assumptions determine whether respondent-driven sampling (RDS) is an appropriate s...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C V...
BACKGROUND: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol...
People who inject drugs (PWID) are greatly affected by blood borne viruses (BBV). Behavioural survei...
Monitoring injecting drug users' (IDUs) health is challenging because IDUs form a difficult to reach...
BACKGROUND: A recent systematic review observed that HIV prevalence amongst injectors is negligible ...
Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C V...
BackgroundNew, more effective and better-tolerated therapies for hepatitis C (HCV) have made the eli...
: BACKGROUND: A recent systematic review observed that HIV prevalence amongst injectors is negligibl...
Abstract Background New, more effective and better-tolerated therapies for hepatitis C (HCV) have ma...
Social network characteristics of people who inject drugs (PWID) have previously been flagged as pot...
BACKGROUND Hepatitis C virus (HCV) transmission in the UK is driven by injecting drug use. We explo...
Background: People who inject drugs (PWID) are at increased risk of acquiring and transmitting HI...
AbstractBackgroundRespondent Driven Sampling (RDS) is a network or chain sampling method designed to...
Abstract: Several assumptions determine whether respondent-driven sampling (RDS) is an appropriate s...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C V...
BACKGROUND: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol...
People who inject drugs (PWID) are greatly affected by blood borne viruses (BBV). Behavioural survei...
Monitoring injecting drug users' (IDUs) health is challenging because IDUs form a difficult to reach...
BACKGROUND: A recent systematic review observed that HIV prevalence amongst injectors is negligible ...
Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C V...
BackgroundNew, more effective and better-tolerated therapies for hepatitis C (HCV) have made the eli...
: BACKGROUND: A recent systematic review observed that HIV prevalence amongst injectors is negligibl...
Abstract Background New, more effective and better-tolerated therapies for hepatitis C (HCV) have ma...
Social network characteristics of people who inject drugs (PWID) have previously been flagged as pot...
BACKGROUND Hepatitis C virus (HCV) transmission in the UK is driven by injecting drug use. We explo...
Background: People who inject drugs (PWID) are at increased risk of acquiring and transmitting HI...
AbstractBackgroundRespondent Driven Sampling (RDS) is a network or chain sampling method designed to...
Abstract: Several assumptions determine whether respondent-driven sampling (RDS) is an appropriate s...
The risk-related behaviours and practices associated with injection drug use remain a driver of HIV ...
Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C V...